Clinico-pathological features of gynecological myopericytoma: a challenging diagnosis in an exceptional location

  • Fulvio Borella
  • Fabiola Lucchino
  • Luca BerteroEmail author
  • Marisa Ribotta
  • Isabella Castellano
  • Andrea Carosso
  • Stefano Cosma
  • Dionyssios Katsaros
  • Chiara Benedetto
Original Article


Myopericytomas (MPC) are rare mesenchymal tumors, originating from the perivascular myoid cells. They predominantly occur in the skin and superficial soft tissues of the extremities, while visceral involvement is rare. Histological features and clinical course are usually benign. To the best of our knowledge, MPC is still an uncharacterized tumor entity of the female internal genital tract. We describe three MPC cases involving the female internal genital tract: (1) a uterine wall MPC arising in a 49-year-old woman with progressive pelvic/abdominal pain; (2) a cervix MPC of a 49-year-old woman who presented with metrorrhagia, and (3) a MPC presenting as a simple ovarian cyst in a 26-year-old woman with pain located in the left iliac fossa. All patients were surgically treated, and recurrence occurred in two cases. The histological and immunohistochemical findings, supporting the diagnosis of MPC, are presented; in particular, one case showed characteristics pointing towards an uncertain biological behavior/low-grade malignancy. A literature search was conducted to identify previous reports of gynecological MPC and for possible alternative diagnoses. Leiomyoma, epithelioid leiomyoma, angioleiomyoma, perivascular epithelioid cell tumor, solitary fibrous tumor, and low-grade endometrial stromal sarcoma should be considered in the differential diagnosis. Awareness of possible occurrence of this rare neoplasm in the female genital tract is important to reach a correct diagnosis in the spectrum of mesenchymal tumors. Considering the risk of recurrence, we recommend careful evaluation of surgical margins and complete surgical removal whenever possible.


Myopericytoma Differential diagnosis Soft tissue tumor Female genital tract Gynecopathology Gynecology 



The authors would like to thank Dr. Manuela Crispo (University of California, Davis, CA, USA) for the helpful discussion.

Author contributions

FB, FL: study concept, manuscript writing and editing, preparing the graphics. LB: image acquisition and interpretation, pathologic revision, manuscript editing and revision. MR: original diagnosis of MPCs cases, pathologic revision, manuscript revision. IC: pathologic revision, manuscript revision. SC: clinical data collection, manuscript editing, manuscript revision. AC, DK: clinical data collection, literature search, manuscript revision. CB: study concept, manuscript critical review. All authors approved the final version of this manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

428_2019_2645_MOESM1_ESM.docx (18 kb)
ESM 1 (DOCX 17 kb)


  1. 1.
    Granter SR, Badizadegan K, Fletcher CD (1998) Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. Am J Surg Pathol 22:513–525CrossRefGoogle Scholar
  2. 2.
    Fletcher CD, Bridge JA, Hogendoorn PCW, Mertens F (2013) World Health Organization classification of tumors of soft tissue and bone. 4th ednGoogle Scholar
  3. 3.
    Mentzel T, Dei Tos AP, Sapi Z, Kutzner H (2006) Myopericytoma of skin and soft tissues: clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol 30:104–113CrossRefGoogle Scholar
  4. 4.
    Zhao M, Williamson SR, Sun K (2014) Benign perivascular myoid cell tumor (myopericytoma) of the urinary tract: a report of 2 cases with an emphasis on differential diagnosis. Hum Pathol 45:1115–1121CrossRefGoogle Scholar
  5. 5.
    Song XL, Sun XY, Zhang GL, Yu YW, Wang CH (2012) Myopericytoma presenting as multiple pulmonary nodules. Intern Med 51:639–642CrossRefGoogle Scholar
  6. 6.
    Mannan AASR, McGinty J, Theise N (2016) Myopericytoma of the liver. Am J Surg Pathol 146(suppl_1):246Google Scholar
  7. 7.
    Nassereddine H, Cazes A, Verdonk C, Assours B, Dautry R, Nataf P, Wassef M, Deschamps L (2017) Atrial angioleiomyoma with myopericytoma-like features: a case report. Cardiovas Pathol 28:7–10CrossRefGoogle Scholar
  8. 8.
    Holling M, Wildförster U, Verheggen R, Müller K, Stummer W, Jeibmann A (2015) Myopericytoma: a series of 5 cases affecting the nervous system. World Neurosurg 84:1493.e5–1493.e8CrossRefGoogle Scholar
  9. 9.
    Patrick A, Soares-de-Almeida L, Heinz K (2016) Malignant myopericytoma: report of a new case and review of the literature. Am J Dermatopathol 38:307–311CrossRefGoogle Scholar
  10. 10.
    McMenamin ME, Fletcher CDM (2002) Malignant myopericytoma: expanding the spectrum of tumors with myopericytic differentiation. Histopathology 41:450–460CrossRefGoogle Scholar
  11. 11.
    Critchley HO, Brenner RM, Henderson TA, Williams K, Nayak NR, Slayden OD, Millar MR, Saunders PT (2001) Estrogen receptor β, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocinol Metab 86(3):1370–1378Google Scholar
  12. 12.
    Stewart EA (2001) Uterine Fibroids. Lancet 357(9592):293–298CrossRefGoogle Scholar
  13. 13.
    Medikare V, Kandukuri LR, Ananthapur V, Deenadayal M, Nallari P (2011) The genetic bases of uterine fibroids; a review. J Reprod Infertil 12:181–191Google Scholar
  14. 14.
    Hodge JC, Quade BJ, Rubin MA, Stewart EA, Dal Cin P, Morton CC (2008) Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids. Am J Pathol 172(5):1403–1410CrossRefGoogle Scholar
  15. 15.
    Holzmann C, Markowski DN, Koczan D, Helmke BM, Bullerdiek J (2014) Genome-wide acquired uniparental disomy as well as chromosomal gains and losses in an uterine epithelioid leiomyoma. Mol Cytogenet 7(1):19CrossRefGoogle Scholar
  16. 16.
    Sahu L, Tempe A, Agrawal A (2012) Angioleiomyoma of uterus. J Obstet Gynaecol 32:713–714CrossRefGoogle Scholar
  17. 17.
    Matsuyama A, Hisaoka M, Hashimoto H (2007) Angioleiomyoma: a clinicopathologic and immunohistochemical reappraisal with special reference to the correlation with myopericytoma. Hum Pathol 38(4):645–651CrossRefGoogle Scholar
  18. 18.
    Garg G, Sambit K (2014) Uterine angioleiomyoma: a rare variant of uterine leiomyoma. Arch Pathol Lab Med 138(8):1115–1118CrossRefGoogle Scholar
  19. 19.
    Wilkinson N, Griffin NR (2018) Problematic areas and new developments in uterine mesenchymal tumors. Diagn Histopathol 24(1):32–44CrossRefGoogle Scholar
  20. 20.
    Diwaker P, Pradhan D, Garg G, Bisaria D, Gogoi K, Mohanty SK (2015) Uterine angioleiomyoma: a rare variant of uterine leiomyoma - a case report and literature review. J Can Res Ther 11(3):649Google Scholar
  21. 21.
    Galindo LJ, Hernández-Beeftink T, Salas A, Jung Y, Reyes R, de Oca FM, Almeida TA (2018) HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas. Gynecol Oncol 150(3):562–568CrossRefGoogle Scholar
  22. 22.
    Xie J, Ubango J, Ban Y, Chakravarti D, Kim JJ, Wei JJ (2018) Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations. Genes Chromosom Cancer 57(10):485–494CrossRefGoogle Scholar
  23. 23.
    Acosta AM, Adley BP (2017) Predicting the behavior of perivascular epithelioid cell tumors of the uterine corpus. Arch Pathol Lab Med 141:463–469CrossRefGoogle Scholar
  24. 24.
    Yamada Y, Yamamoto H, Ohishi Y, Nishiyama K, Fukuhara M, Saitou T, Tsuneyoshi M, Oda Y (2011) Sclerosing variant of perivascular epithelioid cell tumor in the female genital organs. Pathol Int 61(12):768–772CrossRefGoogle Scholar
  25. 25.
    Yang EJ, Howitt BE, Fletcher CDM, Nucci MR (2018) Solitary fibrous tumor of the female genital tract: a clinicopathological analysis of 25 cases. Histopathology 72:749–759CrossRefGoogle Scholar
  26. 26.
    Oliva E (2014) Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations. Int J Gynecol Pathol 33(4):374–384CrossRefGoogle Scholar
  27. 27.
    Chu PG, Arber DA, Weiss LM, Chang KL (2001) Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol 14(5):465–471CrossRefGoogle Scholar
  28. 28.
    Xue WC, Cheung AN (2011) Endometrial stromal sarcoma of uterus. Best Pract Res Clin Obstet Gynaecol 25:719–732CrossRefGoogle Scholar
  29. 29.
    Ip PP, Cheung AN (2011) Pathology of uterine leiomyosarcomas and smooth muscle tumors of uncertain malignant potential. Best Pract Res Clin Obstet Gynaecol 25(6):691–704CrossRefGoogle Scholar
  30. 30.
    Koivisto-Korander R, Butzow R, Koivisto AM, Leminen A (2011) Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers. Tumor Biol 32(3):451–459CrossRefGoogle Scholar
  31. 31.
    Usman A, Khan Lakhnana N, Zafar H (2017) Wide spread low grade endometrial stromal sarcoma. Int J Pathol 15:31–34Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Obstetrics and Gynaecology Unit, Department of Surgical SciencesUniversity of TurinTurinItaly
  2. 2.Pathology Unit, Department of Medical SciencesUniversity of TurinTurinItaly

Personalised recommendations